Predisease conditions and serum vitamin D levels in healthy Mexican American adults

Postgraduate Medicine

Volumn 124, Issue 5, 2012, Pages 136-142

  Gupta, Alok K ^a   Brashear, Meghan M ^a   Johnson, William D ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

CVD risk; Fasting plasma glucose; Preclinical disease; Preventive medicine; Resting blood pressure

Indexed keywords

VITAMIN D;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; NORMAL HUMAN; PREHYPERTENSION; RACE DIFFERENCE; UNITED STATES; VITAMIN BLOOD LEVEL; BLOOD; LIVER; METABOLISM; NUTRITION; STATISTICAL MODEL;

ADULT; BODY MASS INDEX; FEMALE; HUMANS; LIVER; LOGISTIC MODELS; MALE; MEXICAN AMERICANS; NUTRITION SURVEYS; PREDIABETIC STATE; PREHYPERTENSION; VITAMIN D;

EID: 84873250354     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.09.2599     Document Type: Article

References (27)

1. Need AG, O'Loughlin PD, Morris HA, Coates PS, Horowitz M, Nordin BE. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res. 2008;23(11):1859-1863.
2. Nair-Shalliker V, Clements M, Fenech M, Armstrong BK. Personal sun exposure and serum 25-hydroxyvitamin D concentrations [published online ahead of print July 10, 2012]. Photochem Photobiol.
3. Gupta AK, Brashear MM, Johnson WD. Low vitamin D levels, prediabetes and prehypertension in healthy African American adults. Nutr Metab Cardiovasc Dis. 2012;22(10):877-882.
4. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3): 690-693.
5. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29(6):726-776.
6. Boucher BJ. Vitamin D insufficiency and diabetes risks. Curr Drug Targets. 2011;12(1):61-87.
7. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol. 2009; 6(10):621-630.
8. Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN. Vitamin D and metabolic syndrome: is there a link? Curr Pharm Des. 2010; 16(30):3417-3434.
9. Forman JP, Williams JS, Fisher ND Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010; 55(5):1283-1288.
10. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168(12):1340-1349.
11. Gupta AK, Brashear MM, Johnson WD. Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care. 2011;34(3):658-660.
12. Grant WB, Peiris AN. Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States. J Am Med Dir Assoc. 2010;11(9):617-628.
13. Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol. 2009;20(12):2631-2639.
14. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med. 2010;8(1):11-18.
15. Bodnar LM, Simhan HN. Vitamin D may be a link to black-white disparities in adverse birth outcomes. Obstet Gynecol Surv. 2010; 65(4):273-284.
16. Reis JP, Michos ED, von Mühlen D, Miller ER 3rd. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr. 2008;88(6):1469-1477.
17. Wright NC, Chen L, Niu J, et al. Defining physiologically "normal" vitamin D in African Americans [published online ahead of print December 22, 2011]. Osteoporos Int.
18. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care. 2007;30(suppl 1):S4-S41.
19. Chobanian AV Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
20. Centers for Disease Control and Prevention; US Dept of Health and Human Services; National Center for Health Statistics. Revised Analytical Note for NHANES 2000-2006 and NHANES III (1988-1994) 25-Hydroxyvitamin D Analysis (Revised November 2010). http://www.cdc.gov/nchs/data/nhanes/nhanes3/VitaminD_ana-lyticnote.pdf. Accessed May 24, 2012.
21. Sabanayagam C, Shankar A, Somasundaram S. Serum vitamin D level and prehypertension among subjects free of hypertension. Kidney Blood Press Res. 2012;35(2):106-113.
22. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int. 2009;20(8):1407-1415.
23. Bischoff-Ferrari HA. Vitamin D and fracture prevention. Rheum Dis Clin North Am. 2012;38(1):107-113.
24. Pilz S, März W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008;93(10):3927-3935.
25. Thomas GN, óHartaigh B, Bosch JA, et al. Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Diabetes Care. 2012;35(5):1158-1164.
26. Cozzolino M, Stucchi A, Rizzo MA, et al. Vitamin D receptor activation and prevention of arterial ageing. Nutr Metab Cardiovasc Dis. 2012;22(7):547-552.
27. Al-Daghri NM, Alkharfy KM, Al-Saleh Y, et al. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism. 2012;61(5):661-666.